OIG Cites Fraud, Waste and Abuse Concerns with Skin Substitutes 

compliance risk for OIG skin sub

Many compliance professionals rely on HHS OIG focus areas as they perform risk assessments and plan subsequent auditing and monitoring activities. In November 2024, the OIG added an item to their Work Plan describing their intention to review Medicare Part B payments for skin substitutes.  

This blog explores the implications for compliance and what health systems need to be aware of.  

Continue reading

Three Strategies to Align Compliance with Revenue Cycle 

align compliance with revenue cycle

The revenue cycle is the process that starts with a patient’s initial appointment and ends with full payment for services. It encompasses all the administrative and clinical functions that contribute to collecting patient service revenue.  For healthcare organizations that provide services to patients, the revenue cycle is the organization’s financial lifeblood. 

Continue reading

What Happens When Integrity and Accountability Fail: Lessons for Compliance Professionals 

“The U.S. opioid epidemic holds important lessons for compliance professionals. This public health crisis is characterized by the widespread misuse of opioid drugs, leading to addiction, overdose deaths and a profound social and economic toll.  

This epidemic has evolved over the past few decades, and while there are many contributing factors, the role of pharmaceutical companies, particularly in the early stages, is widely seen as a critical element.”

Continue reading